ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.23
-0.07%
US Tech 100
21,403.60
-0.57%
S&P 500
6,050.61
-0.39%
US Dollar vs CAD
1.43233
0.10%
Bitcoin
104,399.68
-1.67%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pulmonx Corporation (LUNG) Share Price

Pulmonx Corporation

Pulmonx Corporation (LUNG)

NASDAQ
6.13
-0.07
(-1.13%)
Closed December 17 3:00PM
Delayed by 15 minutes
6.13
0.00
(0.00%)
After Hours: 4:30PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.13
Bid
4.50
Ask
7.48
Volume
145,355
6.065 Day's Range 6.24
5.46 52 Week Range 14.92
Market Cap
242.061M
Previous Close
6.20
Open
6.16
Last Trade
4186
@
6.13
(formt)
Last Trade Time
Financial Volume
US$ 892,325
VWAP
6.1389
Average Volume (3m)
208,136
Shares Outstanding
39,487,879
Dividend Yield
-
PE Ratio
-3.98
Earnings Per Share (EPS)
-1.54
Revenue
68.68M
Net Profit
-60.84M

About Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.pulmonx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Pulmonx Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUNG. The last closing price for Pulmonx was US$6.20. Over the last year, Pulmonx shares have traded in a share price range of US$ 5.46 to US$ 14.92.

Pulmonx currently has 39,487,879 shares outstanding. The market capitalization of Pulmonx is US$244.82 million. Pulmonx has a price to earnings ratio (PE ratio) of -3.98.

Ask ADVFN Intelligence (AI)

LUNG Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

December 04 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 04 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 26 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

November 22 2024
Edgar (US Regulatory)

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 20 2024
GlobeNewswire Inc.

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for...

November 19 2024
Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 07 2024
GlobeNewswire Inc.

Pulmonx to Present at the Stifel 2024 Healthcare Conference

REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 05 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 01 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2755-4.300991335576.40556.95.9153136926.23683883CS
40.060.9884678747946.077.095.842190516.36649024CS
12-2.05-25.06112469448.188.595.842081366.73130636CS
260.356.05536332185.788.795.462728346.87819863CS
52-6.18-50.203086921212.3114.925.463727118.6947608CS
156-24.12-79.735537190130.2536.264.0739618812.86280989CS
260-31.87-83.86842105263869.47794.0737789320.80520012CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUKKNukkleus Inc
US$ 11.655
(738.49%)
174.4M
PRTGPortage Biotech Inc
US$ 8.8678
(172.86%)
36.61M
OPTXSyntec Optics Holdings Inc
US$ 3.55
(99.44%)
93.16M
PTPIPetros Pharmaceuticals Inc
US$ 0.4976
(86.37%)
63.49M
LUXHLuxUrban Hotels Inc
US$ 0.849899
(59.67%)
29.52M
VCNXVaccinex Inc
US$ 1.41
(-61.37%)
744.49k
TNYATenaya Therapeutics Inc
US$ 1.395
(-51.56%)
42.02M
ORKTOrangeKloud Technology Inc
US$ 2.14
(-41.85%)
2.29M
RVPHReviva Pharmaceuticals Holdings Inc
US$ 1.395
(-39.35%)
17.77M
DBGIDigital Brands Group Inc
US$ 2.46
(-37.88%)
787.17k
RIMEAlgorhythm Holdings Inc
US$ 0.0877
(8.27%)
1.13B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.335
(-36.79%)
1B
GOEVCanoo Inc
US$ 0.118
(7.08%)
382.65M
NVDANVIDIA Corporation
US$ 130.39
(-1.22%)
251.69M
XTIAXTI Aerospace Inc
US$ 0.0442
(8.33%)
221.38M

Discussion

View Full Feed
radly radly 2 minutes ago
There it is, another decent little contract and share price falls
KTOS
NebraskaOTC NebraskaOTC 3 minutes ago
LOL. Dude, how many accounts are you trying to keep up with? STFU already.
VXIT
fink fink 3 minutes ago
Someone had to say it.
AZRH
Doc logic Doc logic 4 minutes ago
manibiotech,

How many of those are cell based like the floor plan points to?; ). Best wishes.
NWBO
1vman 1vman 4 minutes ago
*****💩DBMM💩 FUNDERS ??? LMAO !!! the only funders here are toxic note lenders making a killing off of share holders back

ENOUGH SAID HUZZAH🤪 !!!
DBMM
2018trader 2018trader 4 minutes ago
No I’m just going to preach the truth as I feel led by the Holy Spirit.
SPY
rooster rooster 5 minutes ago
We need more plants keep people working
lvhd lvhd 5 minutes ago
Crash?
NVDA
Lime Time Lime Time 5 minutes ago
Slow rise up to .05 GVSI

Then we get the share reductions and name Change/Merger in 2025

Huge run in the making
GVSI
nowwhat2 nowwhat2 6 minutes ago
b]2 HOURS LATER........HI, HEY, TELL ME, IS......... .
https://investorshub.advfn.com/uimage/uploads/2024/12/17/frlpebtc_121212_17_CAPT_715pm_FOMC_TRW_SUB_TL.jpg

https://investorshub.advfn.com/uimage/uploads/2024/12/17/[sdkjbtc_121212_17_1m_715pm_FOMC_TRW_SUB_TL.jpg
XRPUSD
lvhd lvhd 6 minutes ago
Pump will crash at some point 
AAPL
StayHumble StayHumble 6 minutes ago
UPDATE💹Funders Wait 💹2Ensure $DBMM Still Trades💹idiot.

$DBMM has the Ability to move forward, to continue to grow its business, benefits its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its registration.
DBMM
XMaster2023 XMaster2023 6 minutes ago
The Longs will hold you to that commitment.
NWBO
lvhd lvhd 7 minutes ago
How much?
QQQ
blackhawks blackhawks 7 minutes ago
Breaking.....

https://scontent-lga3-1.xx.fbcdn.net/v/t39.30808-6/470210353_9343793572305802_8848145622218133305_n.jpg?_nc_cat=108&ccb=1-7&_nc_sid=127cfc&_nc_ohc=h6dki-BqE3YQ7kNvgEDbV_Q&_nc_zt=23&_nc_ht=scontent-lga3-1.xx&_nc_gid=AgXZZefL7NyJzjFs6ogdvgy&oh=00_AYBg0AEWIEprjNATtjJNbt7khw
lvhd lvhd 8 minutes ago
It's gonna be worst next year. Hope you don't loose too much 
AMD
Golden Cross Golden Cross 8 minutes ago
Here is why Delta...

here is his post... They bash it it get it to the point where they want to buy it...Sad and criminal

https://investorshub.advfn.com/uimage/uploads/2024/12/17/wqucibasher.png
BEGI
blackhawks blackhawks 9 minutes ago
To be replaced with WHAT exactly? Junk science spouting assholes who don't know a virus from bacteria and who want to bring back polio, smallpox, diphtheria and cavities?

Ain't gonna happen. Be happy with the tariffs, deportations and resultant, predictable, recession.
sortagreen sortagreen 12 minutes ago
https://scontent-lga3-1.xx.fbcdn.net/v/t39.30808-6/470210353_9343793572305802_8848145622218133305_n.jpg?_nc_cat=108&ccb=1-7&_nc_sid=127cfc&_nc_ohc=h6dki-BqE3YQ7kNvgEDbV_Q&_nc_zt=23&_nc_ht=scontent-lga3-1.xx&_nc_gid=AgXZZefL7NyJzjFs6ogdvgy&oh=00_AYBg0AEWIEprjNATtjJNbt7khw9iE8lsvepg6gIfqvWdmQ&oe=67681
TalShu TalShu 13 minutes ago
Laurent,
The are no files to this link.
Can you please tell us WHO opposed the patent.
Thanks
AMRN
John Doe 2024 John Doe 2024 13 minutes ago
With their prior track record it's hard to get excited about anything but hopefully all the longs will finally be rewarded soon.
XERI
blackhawks blackhawks 14 minutes ago
When you do not.....

https://scontent-lax3-2.xx.fbcdn.net/v/t39.30808-6/470214445_1055362429968573_5850941613585381374_n.jpg?_nc_cat=106&ccb=1-7&_nc_sid=833d8c&_nc_ohc=0a38FRrnBj4Q7kNvgHoENzu&_nc_zt=23&_nc_ht=scontent-lax3-2.xx&_nc_gid=A9MkGJa5SjxGGkVZFSNOVi1&oh=00_AYCRwzHk-ti2NjvYfWQ
EarningsCentral EarningsCentral 16 minutes ago
MITK
nowwhat2 nowwhat2 17 minutes ago
2 HOURS LATER........HI, HEY, TELL ME, IS......... .
https://investorshub.advfn.com/uimage/uploads/2024/12/17/frlpebtc_121212_17_CAPT_715pm_FOMC_TRW_SUB_TL.jpg

https://investorshub.advfn.com/uimage/uploads/2024/12/17/[sdkjbtc_121212_17_1m_715pm_FOMC_TRW_SUB_TL.jpg
BTCUSD
nwtf nwtf 17 minutes ago
Prove him wrong. You cant as you dont deal in facts.
ERHE

Your Recent History

NASDAQ
LUNG
Pulmonx
COIN
AAABTC
Abulaba Change Your Life
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved